Full Text

Turn on search term navigation

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Primary ciliary dyskinesia (PCD) is a disorder affecting motile cilia. An early accurate diagnosis helps prevent lung damage and preserve lung function. To make a diagnostic assessment, one of the commonly used methods that allows for the examination of ciliary ultrastructure is transmission electron microscopy (TEM). This allows for a quantitative assessment of ciliary components to identify defects associated with PCD. Heavy metal staining is required to provide a contrast when imaging cilia in the TEM. One of the most commonly used stains is uranyl acetate (UA). UA can be applied to cellular material before embedding (en bloc), or to ultrathin sections of embedded samples (grid staining). UA is radioactive and, due to growing safety concerns and restrictions by government bodies, universities and hospitals, it is essential to find a suitable alternative. We show UA-zero (UAZ), when used en bloc, provides a high contrast and is a suitable replacement for UA. PCD diagnostic experts, having reviewed ciliary cross-sections stained with UAZ en bloc, are confident that the staining and PCD defects are readily detectable similar to samples that have been stained with UA.

Details

Title
UA-Zero as a Uranyl Acetate Replacement When Diagnosing Primary Ciliary Dyskinesia by Transmission Electron Microscopy
Author
Pinto, Andreia Lucia 1   VIAFID ORCID Logo  ; Rai, Ranjit Kaur 2   VIAFID ORCID Logo  ; Shoemark, Amelia 3 ; Hogg, Claire 4 ; Burgoyne, Thomas 5 

 Royal Brompton Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London SW3 6NP, UK; [email protected] (A.L.P.); [email protected] (R.K.R.); [email protected] (A.S.); [email protected] (C.H.); Department of Life Sciences, NOVA School of Science and Technology, 2829-516 Caparica, Portugal 
 Royal Brompton Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London SW3 6NP, UK; [email protected] (A.L.P.); [email protected] (R.K.R.); [email protected] (A.S.); [email protected] (C.H.) 
 Royal Brompton Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London SW3 6NP, UK; [email protected] (A.L.P.); [email protected] (R.K.R.); [email protected] (A.S.); [email protected] (C.H.); School of Medicine, University of Dundee, Dundee DD1 9SY, UK 
 Royal Brompton Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London SW3 6NP, UK; [email protected] (A.L.P.); [email protected] (R.K.R.); [email protected] (A.S.); [email protected] (C.H.); Department of Paediatrics, Imperial College London, London SW3 6LY, UK 
 Royal Brompton Hospital, Guy’s and St Thomas’ NHS Foundation Trust, London SW3 6NP, UK; [email protected] (A.L.P.); [email protected] (R.K.R.); [email protected] (A.S.); [email protected] (C.H.); UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK 
First page
1063
Publication year
2021
Publication date
2021
Publisher
MDPI AG
e-ISSN
20754418
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2544724426
Copyright
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.